Back to all studiesWithdrawnNCT04811404
A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid
Medication studyAges 18–60United StatesBipolarity
The study in practiceUnderstand this study
Who could participate?
Listed age limits: 18 years to 60 years.
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarifyThis summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Study clarityThings to check before joining
Study start dateStarted: March 19, 2021
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT04811404
- Official title
Show the full official title
A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid
Questions about this study?
The HopeStage team will email you.
A listed location does not confirm current availability.
FAQQuestions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Ethyl Eicosapentaenoic Acid.
Who can participate?
Listed age limits: 18 years to 60 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
Explore other studiesWant to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me